Nirvana
PrivateLast Round
Series A
Sep 12, 2024
Total Funding Raised
$31.7M
Company Overview
Nirvana is a healthcare technology company that leverages AI to automate insurance eligibility checks and cost share estimates for patients and providers.
Sector
Healthcare & Life Sciences
Verticals
Revenue Cycle, Vertical SaaS, Medical AI, Workflow Automation, Mental Health
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nirvana Comps
Public and private peers based on sector, stage, and business model.
Nirvana Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 12, 2024 | ||||
| Seed | Nov 17, 2021 |
Key People
Founding team and executive leadership
Nirvana Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eniac Ventures | Series A, Seed |
| Northzone | Series A |
| Surface Ventures | Series A |
| Inspired Capital | Series A, Seed |
| Arc Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
LifeStance Health, Modern Health, and Headspace are new customers.
- Oct 1, 2025
Added Ayble Health, Inc. as a customer.
Nirvana Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nirvana's valuation, stock price, and market status.
